Huang, W., Li, L., Zhou, Y., Yang, Q., Mixdorf, J. C., Barnhart, T. E., . . . Cai, W. (2025). Preclinical evaluation of zirconium-89 labeled anti-Trop2 antibody–drug conjugate (Trodelvy) for imaging in gastric cancer and triple-negative breast cancer. European Journal of Nuclear Medicine and Molecular Imaging, 52(7), 2369-2383. https://doi.org/10.1007/s00259-025-07106-4
Chicago-referens (17:e uppl.)Huang, Wenpeng, et al. "Preclinical Evaluation of Zirconium-89 Labeled Anti-Trop2 Antibody–drug Conjugate (Trodelvy) for Imaging in Gastric Cancer and Triple-negative Breast Cancer." European Journal of Nuclear Medicine and Molecular Imaging 52, no. 7 (2025): 2369-2383. https://doi.org/10.1007/s00259-025-07106-4.
MLA-referens (9:e uppl.)Huang, Wenpeng, et al. "Preclinical Evaluation of Zirconium-89 Labeled Anti-Trop2 Antibody–drug Conjugate (Trodelvy) for Imaging in Gastric Cancer and Triple-negative Breast Cancer." European Journal of Nuclear Medicine and Molecular Imaging, vol. 52, no. 7, 2025, pp. 2369-2383, https://doi.org/10.1007/s00259-025-07106-4.
